Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury

European Journal of Pharmacology

Volumn 638, Issue 1-3, 2010, Pages 150-155

  Liu, Weihua ^a   Zhang, Xiaoyan ^b   Liu, Peiqing ^a   Shen, Xiaoyan ^a   Lan, Tian ^a   Li, Wenyuan ^a   Jiang, Qin ^a   Xie, Xi ^a   Huang, Heqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU RED CROSS HOSPITAL   (China)

Author keywords

Berberine; Diabetic nephropathy; Fibronectin; Intercellular adhesion molecule 1; NF kappa B; Transforming growth factor beta 1

Indexed keywords

ALLOXAN; BERBERINE; FIBRONECTIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA1; I KAPPA B; NF-KAPPAB INHIBITOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOWN REGULATION; EXTRACELLULAR MATRIX; GLOMERULUS; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STAINING; TISSUE DISTRIBUTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; FIBROSIS; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY;

ANIMALS; BERBERINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOWN-REGULATION; EXTRACELLULAR MATRIX; FIBRONECTINS; FIBROSIS; I-KAPPA B PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953537219     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.033     Document Type: Article

References (43)

1. Bondar I.A., Klimontov V.V., Nadeev A.P. Urinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathy. Ter. Arkh. 2008, 80:52-56.
2. Brosius F.C. New insights into the mechanisms of fibrosis and sclerosis in diabetic nephropathy. Rev. Endocr. Metab. Disord. 2008, 9:245-254.
3. Brown W.V. Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection. Am. J. Cardiol. 2008, 102:10L-13L.
4. Catania J.M., Chen G., Parrish A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am. J. Physiol. Renal. Physiol. 2007, 292:F905-F911.
5. Chen S., Jim B., Ziyadeh F.N. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin. Nephrol. 2003, 23:532-543.
6. Chow F.Y., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol. Dial. Transplant. 2004, 19:2987-2996.
7. Chow F.Y., Nikolic-Paterson D.J., Ozols E., Atkins R.C., Tesch G.H. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J. Am. Soc. Nephrol. 2005, 16:1711-1722.
8. Forbes J.M., Fukami K., Cooper M.E. Diabetic nephropathy: where hemodynamics meets metabolism. Exp. Clin. Endocrinol. Diabetes 2007, 115:69-84.
9. Gambaro G., Weigert C., Ceol M., Schleicher E.D. Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis. Contrib. Nephrol. 2001, 107-113.
10. Gao Z., Tang Y., Chen J., Bai R., Zhang Q., Hou Y., Lu Y., Bai G. A novel DPP-IV-resistant analog of glucagon-like peptide-1 (GLP-1): KGLP-1 alone or in combination with long-acting PLGA microspheres. Peptides 2009, 30:1874-1881.
11. Guo J., Liu T., Han L., Liu Y. The effects of corn silk on glycaemic metabolism. Nutr. Metab. (Lond.) 2009, 6:47.
12. Hofmann M.A., Schiekofer S., Isermann B., Kanitz M., Henkels M., Joswig M., Treusch A., Morcos M., Weiss T., Borcea V., Abdel Khalek A.K., Amiral J., Tritschler H., Ritz E., Wahl P., Ziegler R., Bierhaus A., Nawroth P.P. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia 1999, 42:222-232.
13. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621-663.
14. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., Jiang J.D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 2004, 10:1344-1351.
15. Kuhad A., Chopra K. Attenuation of diabetic nephropathy by tocotrienol: involvement of NF-κB signaling pathway. Life Sci. 2009, 84:296-301.
16. Lan Y., Zhou Q., Wu Z.L. NF-kappa B involved in transcription enhancement of TGF-beta 1 induced by Ox-LDL in rat mesangial cells. Chin. Med. J. (Engl.) 2004, 117:225-230.
17. Liu W., Liu P., Tao S., Deng Y., Li X., Lan T., Zhang X., Guo F., Huang W., Chen F., Huang H., Zhou S.F. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Arch. Biochem. Biophys. 2008, 475:128-134.
18. Liu W.H., Hei Z.Q., Nie H., Tang F.T., Huang H.Q., Li X.J., Deng Y.H., Chen S.R., Guo F.F., Huang W.G., Chen F.Y., Liu P.Q. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin. Med. J. 2008, 121:706-712.
19. Liu W., Tang F., Deng Y., Li X., Lan T., Zhang X., Huang H., Liu P. Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition. Mol. Cell. Biochem. 2009, 325:99-105.
20. Mason R.M., Wahab N.A. Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 2003, 14:1358-1373.
21. Menini S., Amadio L., Oddi G., Ricci C., Pesce C., Pugliese F., Giorgio M., Migliaccio E., Pelicci P., Iacobini C., Pugliese G. Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 2006, 55:1642-1650.
22. Mora C., Navarro J.F. The role of inflammation as a pathogenic factor in the development of renal disease in diabetes. Curr. Diab. Rep. 2005, 5:399-401.
23. Morigi M., Angioletti S., Imberti B., Donadelli R., Micheletti G., Figliuzzi M., Remuzzi A., Zoja C., Remuzzi G. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J. Clin. Invest. 1998, 101:1905-1915.
24. Murphy M., Crean J., Brazil D.P., Sadlier D., Martin F., Godson C. Regulation and consequences of differential gene expression in diabetic kidney disease. Biochem. Soc. Trans. 2008, 36:941-945.
25. Nam J.S., Cho M.H., Lee G.T., Park J.S., Ahn C.W., Cha B.S., Lim S.K., Kim K.R., Ha H.J., Lee H.C. The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy. Diabetes Res. Clin. Pract. 2008, 81:25-32.
26. Navarro J.F., Mora C. Role of inflammation in diabetic complications. Nephrol. Dial. Transplant. 2005, 20:2601-2604.
27. Navarro J.F., Mora C. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Scientific World Journal 2006, 6:908-917.
28. Ohga S., Shikata K., Yozai K., Okada S., Ogawa D., Usui H., Wada J., Shikata Y., Makino H. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am. J. Physiol. Renal. Physiol. 2007, 292:F1141-F1150.
29. Okada S., Shikata K., Matsuda M., Ogawa D., Usui H., Kido Y., Nagase R., Wada J., Shikata Y., Makino H. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003, 52:2586-2593.
30. Park C.W., Kim J.H., Lee J.H., Kim Y.S., Ahn H.J., Shin Y.S., Kim S.Y., Choi E.J., Chang Y.S., Bang B.K. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. Diabetologia 2000, 43:1544-1553.
31. Rangan G.K., Wang Y., Tay Y.C., Harris D.C. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int. 1999, 56:118-134.
32. Romzova M., Hohenadel D., Kolostova K., Pinterova D., Fojtikova M., Ruzickova S., Dostal C., Bosak V., Rychlik I., Cerna M. NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications. Hum. Immunol. 2006, 67:706-713.
33. Ronn S.G., Borjesson A., Bruun C., Heding P.E., Frobose H., Mandrup-Poulsen T., Karlsen A.E., Rasschaert J., Sandler S., Billestrup N. Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection. Diabetologia 2008, 51:1873-1882.
34. Saraheimo M., Teppo A.M., Forsblom C., Fagerudd J., Groop P.H. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia 2003, 46:1402-1407.
35. Schena F.P., Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J. Am. Soc. Nephrol. 2005, 16(Suppl 1):S30-S33.
36. Schmid H., Boucherot A., Yasuda Y., Henger A., Brunner B., Eichinger F., Nitsche A., Kiss E., Bleich M., Grone H.J., Nelson P.J., Schlondorff D., Cohen C.D., Kretzler M. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006, 55:2993-3003.
37. Shelton M.D., Kern T.S., Mieyal J.J. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: model of diabetic retinopathy. J. Biol. Chem. 2007, 282:12467-12474.
38. Singh J., Kakkar P. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. J. Ethnopharmacol. 2009, 123:22-26.
39. Tang L.Q., Wei W., Chen L.M., Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J. Ethnopharmacol. 2006, 108:109-115.
40. Tomohiro T., Kumai T., Sato T., Takeba Y., Kobayashi S., Kimura K. Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy. Life Sci. 2007, 80:1364-1372.
41. Wolkow P.P., Niewczas M.A., Perkins B., Ficociello L.H., Lipinski B., Warram J.H., Krolewski A.S. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J. Am. Soc. Nephrol. 2008, 19:789-797.
42. Yin J., Xing H., Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008, 57:712-717.
43. Zheng Q., Qiu W.C., Yan J., Wang W.G., Yu S., Wang Z.G., Ai K.X. Prokinetic effects of a ghrelin receptor agonist GHRP-6 in diabetic mice. World J. Gastroenterol. 2008, 14:4795-4799.